Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Dusa to meet with FDA advisory panel to review Levulan

May 6, 1999

Subcutaneous anti-CD3 antibody enters psoriasis trial

May 4, 1999

Inhibitors of 5alpha-reductase claimed by L'Oreal for androgen-dependent skin disorders

April 30, 1999

Cellegy initiates phase II testing of Anogesic in hemorrhoid surgery patients

April 27, 1999

Pruritus: a potential new application for kappa-opioid agonists

April 23, 1999

CXCR receptor antagonists in development at SB for chemokine-mediated disorders

April 23, 1999

TP-508 promotes the wound-healing process via a novel mechanism

April 22, 1999

Shiseido provides methods of promoting hair regrowth

April 22, 1999

Cell proliferation induction (CPI): a novel approach to wound healing

April 21, 1999

Bioglan and Allergan form psoriasis therapy partnership

April 20, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...